Global /India /Healthcare /Drug Manufacturers - General /KILITCH
chevron_leftBack
Kilitch Drugs (India) Ltd. logo

Kilitch Drugs (India) Ltd.

KILITCH
NSE: KILITCH Delayed
154.02INR -0.1%
1.63 USD
As of 21 June 2026, Kilitch Drugs (India) Ltd. has a market cap of $56.58M USD, ranking #29710 globally and #1893 in India. It ranks #2686 in the Healthcare sector, and #950 in the Drug Manufacturers - General industry.
Global Rank
29710
Country Rank
1893
Sector Rank
2686
Industry Rank
950
Key Stats
Market Cap
$56.58MUSD
5.34B INR
Enterprise Value
$56.04MUSD
5.29B INR
Revenue (TTM)
$21.94MUSD
2.07B INR
EBITDA (TTM)
$3.05MUSD
288.13M INR
Net Income (TTM)
$2.8MUSD
264.3M INR
EBITDA Margin
14%
Profit Margin
13%
PE Ratio
20.2
PS Ratio
2.6
PB Ratio
2.0
EV/EBITDA
18.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
187
Founded
1978
Website
kilitch.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.1% 7.3% 11% -4.2% -23% -14%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
KILITCH
Kilitch Drugs (India) Ltd
ISIN: INE729D01010
Shares Out.:
34.962M1 Shares Float: 10.062M2
TV:
SA:
YF:
GF:
BA:
MS:
154.02 INR
Bombay Stock Exchange
MIC: XBOM
524500 (KILITCH)
Kilitch Drugs (India) Ltd
ISIN: INE729D01010
TV:
SA:
YF:
GF:
BA:
MS:
152.75 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kilitch Drugs (India) Ltd.

Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, anticoagulant, narcotic, oncology, ophthalmic, antifungal, corticosteroid, anticoagulant, and other applications, as well as vaccines, veterinary products, iron supplements for anemia, Klavmox, and Onecef. It also provides oral formulations, including tablets, capsules, dry syrup, and oral powder for antibiotic, anti-diabetic, cardiovascular, and other areas; effervescent tablets and powders, such as Roipar, Duregra, and Roivit; and nutritional products, including Celtine. In addition, the company offers cosmetics, which include oil, lotion, liquid to cream, paste in skin, and personal and hair care products; herbal products for use in sore throat and prostate problems, as well as a supplement for diabetes, obesity, libido, and other conditions; ortho rehabilitation and implants; and medical devices comprising C-Seal, a skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Further, it provides PH-7 which reduces acid content of the stomach; SRO kit for treating childhood diarrhea; 9-VIT for use in surgery, extensive burns, fractures, and other trauma; and HPURE for sore throat and cough. The company exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
80K%
39.1
DIVISLAB
$18.38B
1.73T INR
32K%
70.0
$15.17B
1.43T INR
27K%
63.0
$11.73B
1.11T INR
21K%
19.6
MANKIND
$9.87B
931.67B INR
17K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
17K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
1M%
38.1
JNJ
$547.28B
967K%
26.4
ABBV
$360.63B
637K%
97.4
$318.3B
256.25B CHF
562K%
19.9
AZN
$284.64B
215.59B GBP
503K%
27.6
MRK
$274.03B
484K%
15.1
chevron_leftBack